ArticleBMJ open2022

Role of CDK4/6 inhibitors in patients with hormone receptor (HR)-positive, human epidermal receptor-2 negative (HER-2) metastatic breast cancer study protocol for a systematic review, network meta-analysis and cost-effectiveness analysis.

Qiancheng Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.